Morphine in myocardial infarction: balancing on the tight rope

Affiliations

¹ Department of Cardiology, Oslo University Hospital Ullevål, and Faculty of Medicine, University of Oslo, Norway dan.atar@online.no.
² Department of Cardiology, Oslo University Hospital Ullevål, and Faculty of Medicine, University of Oslo, Norway.

Editorial

Dan Atar et al. Eur Heart J. 2016.

. 2016 Jan 14;37(3):253-5.

doi: 10.1093/eurheartj/ehv546. Epub 2015 Oct 21.

¹ Department of Cardiology, Oslo University Hospital Ullevål, and Faculty of Medicine, University of Oslo, Norway dan.atar@online.no.
² Department of Cardiology, Oslo University Hospital Ullevål, and Faculty of Medicine, University of Oslo, Norway.

No abstract available

Comment on

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
Kubica J, Adamski P, Ostrowska M, Sikora J, Kubica JM, Sroka WD, Stankowska K, Buszko K, Navarese EP, Jilma B, Siller-Matula JM, Marszałł MP, Rość D, Koziński M. Kubica J, et al. Eur Heart J. 2016 Jan 14;37(3):245-52. doi: 10.1093/eurheartj/ehv547. Epub 2015 Oct 21. Eur Heart J. 2016. PMID: 26491112 Free PMC article. Clinical Trial.